Hepatitis C core antigen testing to diagnose active hepatitis C infection among haemodialysis patients

BACKGROUND: Hepatitis C virus (HCV) infects more than 71 million people worldwide and chronic HCV infection increases the risk of liver cirrhosis and failure. Haemodialysis (HD) is one of the renal replacement therapies with risk of HCV transmission. Anti-HCV antibodies are the serological screening...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Xue Zheng, Gan, Chye Chung, Mohamed, Rosmawati, Yahya, Rosnawati, Ganapathy, Shubash, Tan, Soek Siam, Lim, Soo Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666439/
https://www.ncbi.nlm.nih.gov/pubmed/33187498
http://dx.doi.org/10.1186/s12882-020-02154-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666439/
https://www.ncbi.nlm.nih.gov/pubmed/33187498
http://dx.doi.org/10.1186/s12882-020-02154-4

Ejemplares similares